Lung cancer risk reduction after smoking cessation: Observations from a prospective cohort of women

Jon Owen Ebbert, Ping Yang, Celine M Vachon, R. A. Vierkant, James R Cerhan, A. R. Folsom, T. A. Sellers

Research output: Contribution to journalArticle

134 Citations (Scopus)

Abstract

Purpose: We conducted this study because the duration of excess lung cancer risk among former smokers has been inconsistently reported, doubt has been raised regarding the population impact of smoking cessation, and differential risk reduction by histologic cell type after smoking cessation needs to be confirmed. Methods: The Iowa Women's Health Study is a prospective cohort study of 41,836 Iowa women aged 55 to 69 years. In 1986, mailed questionnaires were used to collect detailed smoking history. Age-adjusted lung cancer incidence through 1999 was analyzed according to years of smoking abstinence. Relative risks were estimated using Cox regression analysis. Results: There were 37,078 women in the analytic cohort. Compared with the never smokers, former smokers had an elevated lung cancer risk (relative risk, 6.6; 95% confidence interval, 5.0 to 8.7) up to 30 years after smoking cessation for all former smokers. However, a beneficial effect of smoking cessation was observed among recent and distant former smokers. The risk of adenocarcinoma remained elevated up to 30 years for both former heavier and former lighter smokers. Conclusion: The risk for lung cancer is increased for both current and former smokers compared with never smokers and declines for former smokers with increasing duration of abstinence. The decline in excess lung cancer risk among former smokers is prolonged compared with other studies, especially for adenocarcinoma and for heavy smokers, suggesting that more emphasis should be placed on smoking prevention and lung cancer chemoprevention.

Original languageEnglish (US)
Pages (from-to)921-926
Number of pages6
JournalJournal of Clinical Oncology
Volume21
Issue number5
DOIs
StatePublished - Mar 1 2003

Fingerprint

Smoking Cessation
Risk Reduction Behavior
Lung Neoplasms
Smoking
Adenocarcinoma
Chemoprevention
Women's Health
Cohort Studies
History
Regression Analysis
Prospective Studies
Confidence Intervals
Incidence
Population

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Lung cancer risk reduction after smoking cessation : Observations from a prospective cohort of women. / Ebbert, Jon Owen; Yang, Ping; Vachon, Celine M; Vierkant, R. A.; Cerhan, James R; Folsom, A. R.; Sellers, T. A.

In: Journal of Clinical Oncology, Vol. 21, No. 5, 01.03.2003, p. 921-926.

Research output: Contribution to journalArticle

@article{e28cf4c1f77847bca41fb5e9572d0ab1,
title = "Lung cancer risk reduction after smoking cessation: Observations from a prospective cohort of women",
abstract = "Purpose: We conducted this study because the duration of excess lung cancer risk among former smokers has been inconsistently reported, doubt has been raised regarding the population impact of smoking cessation, and differential risk reduction by histologic cell type after smoking cessation needs to be confirmed. Methods: The Iowa Women's Health Study is a prospective cohort study of 41,836 Iowa women aged 55 to 69 years. In 1986, mailed questionnaires were used to collect detailed smoking history. Age-adjusted lung cancer incidence through 1999 was analyzed according to years of smoking abstinence. Relative risks were estimated using Cox regression analysis. Results: There were 37,078 women in the analytic cohort. Compared with the never smokers, former smokers had an elevated lung cancer risk (relative risk, 6.6; 95{\%} confidence interval, 5.0 to 8.7) up to 30 years after smoking cessation for all former smokers. However, a beneficial effect of smoking cessation was observed among recent and distant former smokers. The risk of adenocarcinoma remained elevated up to 30 years for both former heavier and former lighter smokers. Conclusion: The risk for lung cancer is increased for both current and former smokers compared with never smokers and declines for former smokers with increasing duration of abstinence. The decline in excess lung cancer risk among former smokers is prolonged compared with other studies, especially for adenocarcinoma and for heavy smokers, suggesting that more emphasis should be placed on smoking prevention and lung cancer chemoprevention.",
author = "Ebbert, {Jon Owen} and Ping Yang and Vachon, {Celine M} and Vierkant, {R. A.} and Cerhan, {James R} and Folsom, {A. R.} and Sellers, {T. A.}",
year = "2003",
month = "3",
day = "1",
doi = "10.1200/JCO.2003.05.085",
language = "English (US)",
volume = "21",
pages = "921--926",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "5",

}

TY - JOUR

T1 - Lung cancer risk reduction after smoking cessation

T2 - Observations from a prospective cohort of women

AU - Ebbert, Jon Owen

AU - Yang, Ping

AU - Vachon, Celine M

AU - Vierkant, R. A.

AU - Cerhan, James R

AU - Folsom, A. R.

AU - Sellers, T. A.

PY - 2003/3/1

Y1 - 2003/3/1

N2 - Purpose: We conducted this study because the duration of excess lung cancer risk among former smokers has been inconsistently reported, doubt has been raised regarding the population impact of smoking cessation, and differential risk reduction by histologic cell type after smoking cessation needs to be confirmed. Methods: The Iowa Women's Health Study is a prospective cohort study of 41,836 Iowa women aged 55 to 69 years. In 1986, mailed questionnaires were used to collect detailed smoking history. Age-adjusted lung cancer incidence through 1999 was analyzed according to years of smoking abstinence. Relative risks were estimated using Cox regression analysis. Results: There were 37,078 women in the analytic cohort. Compared with the never smokers, former smokers had an elevated lung cancer risk (relative risk, 6.6; 95% confidence interval, 5.0 to 8.7) up to 30 years after smoking cessation for all former smokers. However, a beneficial effect of smoking cessation was observed among recent and distant former smokers. The risk of adenocarcinoma remained elevated up to 30 years for both former heavier and former lighter smokers. Conclusion: The risk for lung cancer is increased for both current and former smokers compared with never smokers and declines for former smokers with increasing duration of abstinence. The decline in excess lung cancer risk among former smokers is prolonged compared with other studies, especially for adenocarcinoma and for heavy smokers, suggesting that more emphasis should be placed on smoking prevention and lung cancer chemoprevention.

AB - Purpose: We conducted this study because the duration of excess lung cancer risk among former smokers has been inconsistently reported, doubt has been raised regarding the population impact of smoking cessation, and differential risk reduction by histologic cell type after smoking cessation needs to be confirmed. Methods: The Iowa Women's Health Study is a prospective cohort study of 41,836 Iowa women aged 55 to 69 years. In 1986, mailed questionnaires were used to collect detailed smoking history. Age-adjusted lung cancer incidence through 1999 was analyzed according to years of smoking abstinence. Relative risks were estimated using Cox regression analysis. Results: There were 37,078 women in the analytic cohort. Compared with the never smokers, former smokers had an elevated lung cancer risk (relative risk, 6.6; 95% confidence interval, 5.0 to 8.7) up to 30 years after smoking cessation for all former smokers. However, a beneficial effect of smoking cessation was observed among recent and distant former smokers. The risk of adenocarcinoma remained elevated up to 30 years for both former heavier and former lighter smokers. Conclusion: The risk for lung cancer is increased for both current and former smokers compared with never smokers and declines for former smokers with increasing duration of abstinence. The decline in excess lung cancer risk among former smokers is prolonged compared with other studies, especially for adenocarcinoma and for heavy smokers, suggesting that more emphasis should be placed on smoking prevention and lung cancer chemoprevention.

UR - http://www.scopus.com/inward/record.url?scp=0037363052&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037363052&partnerID=8YFLogxK

U2 - 10.1200/JCO.2003.05.085

DO - 10.1200/JCO.2003.05.085

M3 - Article

C2 - 12610194

AN - SCOPUS:0037363052

VL - 21

SP - 921

EP - 926

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 5

ER -